CCL5 and breast carcinoma: In EO771 mammary carcinoma cells, knockdown of PLAC1 resulted in the reduced expression of several inflammatory and immune factors, including Cxcl1, Ccl5, Ly6a/Sca-1, Ly6c, and leukemia inhibitory factor [45].